Trial Profile
Randomised Double-Blind Placebo-Controlled Study of Orally Administered ATL-104 to Assess Safety, Tolerance and Effect on Oral Mucositis in Patients Following Treatment With Chemotherapy and Peripheral Blood Stem Cell Transplant (PBSCT)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jun 2014
Price :
$35
*
At a glance
- Drugs ATL 104 (Primary)
- Indications Mucositis; Stomatitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Alizyme
- 03 Jun 2014 New trial record